Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research: ADA 2019
Gender Associated with Neuropathic Pain
Development of Heart Disease in Young Adults with Type 1 Diabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Old Malaria Drug Effective In Reducing Blood Glucose
#2 The Incidence of Type 2 Diabetes in Patients Receiving Vitamin D Supplementation — ADA 2019
Editor's Note
Thirty years ago most patients with type 2 diabetes did not develop the disease until they were in their late 60’s. They often did not develop the cardiovascular or kidney problems that we are so worried about today. This was likely due to their advanced age at diagnosis and a shorter lifespan in general. As the onset age of type 2 diabetes has become younger in the last three decades we have seen a marked increase in CVD, and we treat these patients more aggressively than ever.
We also look at our type 1 patients differently and have figured out that early and aggressive glucose control will reduce later in life complications. But what about aggressively treating one of the major causes of CVD, hypertension?
For years the guidelines we followed were 140/90, but this week our intern, Maya Rudolph, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, PharmD Candidate, makes a strong case for targeting 120/80 in these younger patients.
Dave Joffe
Editor-in-chief
TOP STORIES -- Diabetes News and Research
The CARMELINA trial demonstrated noninferiority of linagliptin compared with placebo in CV events in high risk people with type 2 diabetes.
New study findings challenge the link between neuropathic pain and vitamin D levels in people with type 2 diabetes.
Could older recommendations of maintaining a blood pressure of 140/90 mmHg be misleading in younger adults with type 1 diabetes for cardiovascular risk reduction?